Abbott beats forecasts on strong COVID-19 testing business

Revenue from the company's diagnostics segment rose 23% to $857 million as demand surged for Covid-19 tests. Abbott's diagnostics growth was fueled by its sales of both lab-based tests and on-site tests.
via FOX BUSINESS NEWS https://ift.tt/32rCy6C
No comments:
Post a Comment